Evidence map›Paper›PMID 35497370›Full record

ArticleBone reports2022

Tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1a.

Masatsune Itoh, Michiko Okajima, Yuko Kittaka, Akihiro Yachie, Taizo Wada, Yutaka Saikawa

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bone reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Masatsune ItohDepartment of Pediatrics, Kanazawa Medical University, Kanazawa, Japan.
Michiko OkajimaDepartment of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Science, Kanazawa University, Kanazawa, Japan.
Yuko KittakaDepartment of Pediatrics, JA Onomichi General Hospital, Onomichi, Japan.
Akihiro YachieDepartment of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Science, Kanazawa University, Kanazawa, Japan.
Taizo WadaDepartment of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Science, Kanazawa University, Kanazawa, Japan.
Yutaka SaikawaDepartment of Pediatrics, Kanazawa Medical University, Kanazawa, Japan.
Kanazawa University · JPKanazawa Medical University · JPOnomichi General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudohypoparathyroidism type 1a (PHP1a) is a genetic disorder caused by heterozygous loss-of-function mutations on the maternal allele of the

Indexed as

AHO, Albright's hereditary osteodystrophyBMD, bone mineral densityBMI, body mass indexC-PTH, carboxyl terminal fragments of PTHGHRH, growth-hormone-releasing hormoneGsα, Gs-alphaHBS, hungry bone syndromeHPT, hyperparathyroidismPHP1aPHP1a, pseudohypoparathyroidism type 1aPHP1b, pseudohypoparathyroidism type 1bPHP1c, pseudohypoparathyroidism type 1cPHP, pseudohypoparathyroidismPseudohypoparathyroidism 1aPTH, parathyroid hormoneTertiary hyperparathyroidismTSH, thyroid stimulating hormone

Identifiers

PMID35497370
PMCPMC9043659
OpenAlexW4224028329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.